Patents by Inventor Matthew Selby

Matthew Selby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240091781
    Abstract: Disclosed herein are microfluidic test cassettes or chips that are received within a POC diagnostic device, and that can directly test biological samples that have had no or minimal processing to remove PCR inhibitor. The microfluidic test cassettes or chips allow for on-cassette/on-chip processing within the size confines of the cassette/chip by utilizing a same heating zone for multiple processing steps.
    Type: Application
    Filed: October 14, 2021
    Publication date: March 21, 2024
    Inventors: Molly JOWSEY, Matthew SELBY
  • Publication number: 20060020012
    Abstract: This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereofs, wherein R1 to R4 are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
    Type: Application
    Filed: June 20, 2005
    Publication date: January 26, 2006
    Inventors: Lyn Jones, Charles Mowbray, David Price, Matthew Selby, Paul Stupple
  • Publication number: 20050004129
    Abstract: This invention relates to pyrazole derivatives of formula (I) or pharmaceutically acceptable salts, solvates or derivative thereof, wherein R1 to R4, n W, X and Y are defined in the description, and to processes for the preparation thereof, intermediates used in their preparation of, compositions containing them and the uses of such derivatives. The compounds of the present invention bind to the enzyme reverse transcriptase and are modulators, especially inhibitors thereof. As such the compounds of the present invention are useful in the treatment of a variety of disorders including those in which the inhibition of reverse transcriptase is implicated. Disorders of interest include those caused by Human Immunodificiency Virus (HIV) and genetically related retroviruses, such as Acquired Immune Deficiency Syndrome (AIDS).
    Type: Application
    Filed: September 23, 2003
    Publication date: January 6, 2005
    Inventors: Lyn Jones, Charles Mowbray, David Price, Matthew Selby, Paul Stupple